|
ERMP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.7065463465733E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.47881706880071E-13 |
| Normal-vs-Stage2 |
2.23376872554581E-13 |
| Normal-vs-Stage3 |
1.25455201782643E-14 |
| Normal-vs-Stage4 |
1.57651669496772E-14 |
| Stage1-vs-Stage2 |
7.936200E-01 |
| Stage1-vs-Stage3 |
1.54250001660472E-09 |
| Stage1-vs-Stage4 |
5.751300E-04 |
| Stage2-vs-Stage3 |
6.760100E-03 |
| Stage2-vs-Stage4 |
2.461600E-02 |
| Stage3-vs-Stage4 |
6.663000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.76285677564192E-14 |
| Normal-vs-AfricanAmerican |
3.33955085807247E-13 |
| Normal-vs-Asian |
3.56492613207138E-13 |
| Caucasian-vs-AfricanAmerican |
8.409900E-02 |
| Caucasian-vs-Asian |
5.878800E-01 |
| AfricanAmerican-vs-Asian |
7.581800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.71844785465692E-14 |
| Normal-vs-Female |
1.70763403417595E-12 |
| Male-vs-Female |
1.744400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.25926002537381E-14 |
| Normal-vs-Age(41-60Yrs) |
8.22675261247241E-14 |
| Normal-vs-Age(61-80Yrs) |
5.295763827462E-14 |
| Normal-vs-Age(81-100Yrs) |
1.63402624764331E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.334600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.404200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.531900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.432200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.780800E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.699100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.04452035698932E-12 |
| Normal-vs-Grade 2 |
1.4521717162097E-13 |
| Normal-vs-Grade 3 |
2.35367281220533E-14 |
| Normal-vs-Grade 4 |
9.43689570931383E-15 |
| Grade 1-vs-Grade 2 |
1.029590E-01 |
| Grade 1-vs-Grade 3 |
2.555900E-02 |
| Grade 1-vs-Grade 4 |
4.791400E-04 |
| Grade 2-vs-Grade 3 |
3.64529999999919E-05 |
| Grade 2-vs-Grade 4 |
5.82550000000071E-05 |
| Grade 3-vs-Grade 4 |
1.064210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.66866520601161E-12 |
| Normal-vs-ccB subtype |
1.72162284428623E-12 |
| ccA subtype-vs-ccB subtype |
1.604780E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.90638649100583E-14 |
| Normal-vs-N1 |
1.66155977865401E-12 |
| N0-vs-N1 |
6.387400E-01 |
|
|
